Mir-25 is a potential treatment target for myocardial ischemic-reperfusion injury

J Chin Med Assoc. 2020 May;83(5):419-420. doi: 10.1097/JCMA.0000000000000295.

Shang-Feng Yang^{1

2}, Po-Hsun Huang^{3

4

2

5}

¹ Division of Nephrology, Department of Medicine, Cheng Hsin General Hospital, Taipei, Taiwan, ROC.
² Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan, ROC.
³ Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
⁴ Department of Critical Care Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
⁵ Cardiovascular Research Center, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.

No abstract available

Publication types